Case Report: Successful salvage therapy with sulbactam-durlobactam combined with meropenem for carbapenem-resistant Acinetobacter baumannii bloodstream infection in a child after failure of allogeneic hematopoietic stem cell transplantation

Qian Zhang, Chunjing Wang, Zhiheng Ding, Jiayi Lyu, Yu Zhang, Fangyuan Lai, Ruihao Zheng, Sixi Liu · 2026

Read Case Report: Successful salvage therapy with sulbactam-durlobactam combined with meropenem for carbapenem-resistant Acinetobacter baumannii bloodstream infection in a child after failure of allogeneic hematopoietic stem cell transplantation by Qian Zhang, Chunjing Wang, Zhiheng Ding, Jiayi Lyu, Yu Zhang, Fangyuan Lai, Ruihao Zheng, Sixi Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13601292.txt.

Description

Qian Zhang and co-authors report a salvage treatment for a child with a drug-resistant infection in this 2026 case paper. The germ, carbapenem-resistant Acinetobacter baumannii, infects blood and resists top antibiotics. Such infections are a grave risk after stem cell transplants.

The child had two failed donor stem cell transplants and lasting low white cell counts. Standard high-dose drugs did not clear the blood infection. A newer drug pair, sulbactam-durlobactam, was combined with meropenem as a last resort. The infection cleared under this mix. The authors present the case as the first of its kind in a child after transplant, and as a model for similar high-risk care.

Catalog record

CREATORQian Zhang, Chunjing Wang, Zhiheng Ding, Jiayi Lyu, Yu Zhang, Fangyuan Lai, Ruihao Zheng, Sixi Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE19 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13601292

Browse the full library · About the Tower of Babel